» Articles » PMID: 39131475

Procedural Characteristics and Outcomes of Transcatheter Interventions for Aortic Coarctation: A Report From the IMPACT Registry

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although surgical repair was the traditional first-line treatment for native coarctation of the aorta (CoA), balloon angioplasty (BA) and stenting are now increasingly being performed. We aimed to determine the practice patterns and acute outcomes of transcatheter interventions for native coarctation in the largest multicenter registry for congenital catheterization.

Methods: CoA interventions from the IMPACT (IMproving Pediatric and Adult Congenital Treatment) National Cardiovascular Data Registry were analyzed. The procedure choice and acute outcomes were compared among patients with no prior interventions on the aortic isthmus (native CoA). Procedural success was defined as no major adverse events (MAEs) and a final peak gradient of <20 mm Hg and optimal outcome as no MAEs and a final gradient of <10 mm Hg.

Results: Over the 8-year study period, 5928 CoA procedures were performed, of which 1187 were performed in patients with native CoA. In this group, stenting was performed in more then half of children aged >1 year and >90% of those aged >8 years. Procedural success was achieved in >90% of stenting procedures but in only 69% of BAs. Stent implantation was associated with a higher likelihood of optimal gradient (<10 mm Hg) after adjustment for age and baseline characteristics. MAEs were most common in children aged <1 year (14%), occurred in 2% to 2.5% of those aged 1 to 18 years and in 6.6% of adults ( < .001), and were more likely after BA than after stenting (odds ratio, 0.5; 95% CI, 0.28-0.9; unadjusted = .02).

Conclusions: Catheter interventions for native coarctation are performed safely in older children and adults, with a high degree of immediate procedural success, particularly with stenting.

References
1.
Holzer R, Gauvreau K, McEnaney K, Watanabe H, Ringel R . Long-Term Outcomes of the Coarctation of the Aorta Stent Trials. Circ Cardiovasc Interv. 2021; 14(6):e010308. DOI: 10.1161/CIRCINTERVENTIONS.120.010308. View

2.
Sohrabi B, Jamshidi P, Yaghoubi A, Habibzadeh A, Hashemi-Aghdam Y, Moin A . Comparison between covered and bare Cheatham-Platinum stents for endovascular treatment of patients with native post-ductal aortic coarctation: immediate and intermediate-term results. JACC Cardiovasc Interv. 2014; 7(4):416-23. DOI: 10.1016/j.jcin.2013.11.018. View

3.
Krishnamurthy Y, Stefanescu Schmidt A, Bittner D, Scholtz J, Bui A, Reddy R . Subclinical Burden of Coronary Artery Calcium in Patients With Coarctation of the Aorta. Am J Cardiol. 2018; 123(2):323-328. DOI: 10.1016/j.amjcard.2018.10.017. View

4.
Martins J, Zachariah J, Tierney E, Truong U, Morris S, Kutty S . Impact of Treatment Modality on Vascular Function in Coarctation of the Aorta: The LOVE - COARCT Study. J Am Heart Assoc. 2019; 8(7):e011536. PMC: 6509735. DOI: 10.1161/JAHA.118.011536. View

5.
Taggart N, Minahan M, Cabalka A, Cetta F, Usmani K, Ringel R . Immediate Outcomes of Covered Stent Placement for Treatment or Prevention of Aortic Wall Injury Associated With Coarctation of the Aorta (COAST II). JACC Cardiovasc Interv. 2016; 9(5):484-93. DOI: 10.1016/j.jcin.2015.11.038. View